
    
      L-697,661 is a newly identified compound that inhibits HIV replication (reproduction and
      growth) in cell culture. It works together with AZT against HIV.

      Part 1: Twelve patients are randomly assigned to one of two groups. Group 1 patients receive
      AZT for 7 days, followed by AZT plus L-697,661 with food for 56 days. Group 2 patients
      receive no drug for 7 days, followed by L-697,661 with food for 56 days. Antipyrine is
      administered 1 hour prior to study drug on days 8, 22, and 35.

      Part 2: Fifteen patients receive L-697,661 with food, for 8 weeks. Therapy with L-697,661 may
      be extended beyond 8 weeks for up to 24 weeks.
    
  